Skip to content
★ Sign in to follow
TR

Thomas R. Hodgson

Executive
Travelers Companies, Inc.Intermune IncIdenix Pharmaceuticals Inc
Total declarations
42
Companies
3
▲ Purchases (5 ops.)
€72k
▼ Sales (5 ops.)
€1.9M

Latest filing published 04 Feb 2016 for Travelers Companies, INC..

Insider track record

Disclosed buys
5
Disclosed sells
5
Signal history

No signal scores available.

Closed purchases

Market purchases
5

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Thomas R. Hodgson: trading record in brief

Thomas R. Hodgson has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Travelers Companies, Inc., Intermune Inc and Idenix Pharmaceuticals Inc. We count 42 filings; the first trade dates from 4 May 2006 and the latest from 2 February 2016.

Both buying and selling appear: 5 purchases worth €72k, against 5 sales worth €1.9M. On balance, insiders were net sellers of €1.8M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 17 share grants and 15 option exercises.

Half of the purchases are above €15k and half below.

The record was last updated on 4 February 2016 with a share grant in Travelers Companies, Inc. The most recent open-market purchase was published on 17 December 2009, 6,170 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Thomas R. Hodgson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations31 total

25 of 31 declarations